← back to search

François Richard

KU Leuven · BE
Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, Pelvic floor disorders treatments, and Urinary Bladder and Prostate Research.
h-index
41
citations
6,502
works
476
NIH funding
primary concept
email

Recent publications

Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium
Modern Pathology 2024cited by 27position: middledoi
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program
npj Breast Cancer 2024cited by 17position: middledoi
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
Nature Cancer 2023cited by 139position: middledoi
Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
European Journal of Cancer 2023cited by 58position: middledoi
Obesity-associated changes in molecular biology of primary breast cancer
Nature Communications 2023cited by 55position: middledoi
Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast
Nature Communications 2022cited by 156position: middledoi
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
Oncogene 2022cited by 45position: middledoi
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
Modern Pathology 2022cited by 42position: middledoi
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
JNCI Journal of the National Cancer Institute 2020cited by 47position: middledoi
Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients
npj Breast Cancer 2020cited by 41position: middledoi
Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data
Clinical Cancer Research 2019cited by 122position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christine Desmedt · KU Leuven5 papers (2020–2024)Maxim De Schepper · KU Leuven3 papers (2020–2024)Giuseppe Floris · Twitter (United States)3 papers (2020–2024) · 2 papers (2020–2020)Thijs Koorman · Utrecht University2 papers (2022–2024)Patrick W.B. Derksen · Utrecht University2 papers (2022–2024)Hans Wildiers · CHU Dinant Godinne UCL Namur2 papers (2020–2023)Christos Sotiriou · University of California San Diego2 papers (2019–2020)Gitte Zels · KU Leuven2 papers (2023–2024)Freya Mertens · KU Leuven2 papers (2023–2024)Tatjana Geukens · KU Leuven2 papers (2020–2023)Ann Smeets · Universitair Ziekenhuis Leuven2 papers (2020–2023)Patrick Neven · European Organisation for Research and Treatment of Cancer2 papers (2020–2023)Marion Maetens · Catholic University of America2 papers (2023–2024)Kevin Punie · Ziekenhuisnetwerk Antwerpen Stuivenberg2 papers (2020–2023)P. J. van Diest · Altrecht GGZ2 papers (2022–2024)Anne Vincent‐Salomon · Université Paris Sciences et Lettres2 papers (2020–2024)Sophia Leduc · KU Leuven2 papers (2020–2023)John Lövrot · Karolinska Institutet1 papers (2019–2019) · 1 papers (2020–2020)